William H Maisel

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Cardiology patient page. Drug-eluting stents
    William H Maisel
    Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 185 Pilgrim Road, Baker 4, Boston, MA 02215, USA
    Circulation 115:e426-7. 2007
  2. ncbi Patent foramen ovale closure devices: moving beyond equipoise
    William H Maisel
    Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    JAMA 294:366-9. 2005
  3. ncbi Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 294:955-8. 2005
  4. ncbi A device for proximal anastomosis of autologous coronary vein grafts: report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Circulation 112:1516-8. 2005
  5. ncbi Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 295:1901-6. 2006
  6. ncbi Pacemaker and ICD generator reliability: meta-analysis of device registries
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 295:1929-34. 2006
  7. ncbi Identification of the ventricular tachycardia isthmus after infarction by pace mapping
    Corinna B Brunckhorst
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
    Circulation 110:652-9. 2004
  8. ncbi Semper fidelis--consumer protection for patients with implanted medical devices
    William H Maisel
    Medical Device Safety Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA
    N Engl J Med 358:985-7. 2008
  9. ncbi Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy
    William H Maisel
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Am J Ther 12:183-5. 2005
  10. ncbi Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease
    Gustavo Lopera
    Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Cardiovasc Electrophysiol 15:52-8. 2004

Detail Information

Publications42

  1. ncbi Cardiology patient page. Drug-eluting stents
    William H Maisel
    Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 185 Pilgrim Road, Baker 4, Boston, MA 02215, USA
    Circulation 115:e426-7. 2007
  2. ncbi Patent foramen ovale closure devices: moving beyond equipoise
    William H Maisel
    Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    JAMA 294:366-9. 2005
  3. ncbi Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 294:955-8. 2005
  4. ncbi A device for proximal anastomosis of autologous coronary vein grafts: report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Circulation 112:1516-8. 2005
  5. ncbi Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 295:1901-6. 2006
    ..It is not known if increasing device complexity is associated with decreased reliability...
  6. ncbi Pacemaker and ICD generator reliability: meta-analysis of device registries
    William H Maisel
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 295:1929-34. 2006
    ..Despite there being millions of pacemaker and implantable cardioverter-defibrillator (ICD) generator implants worldwide, little is known about device reliability...
  7. ncbi Identification of the ventricular tachycardia isthmus after infarction by pace mapping
    Corinna B Brunckhorst
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
    Circulation 110:652-9. 2004
    ..Pace mapping at sites proximal to the exit may produce a similar QRS with a longer stimulus-to-QRS interval (S-QRS). The aim of the study was to determine whether a VT isthmus could be identified and followed by pace mapping...
  8. ncbi Semper fidelis--consumer protection for patients with implanted medical devices
    William H Maisel
    Medical Device Safety Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA
    N Engl J Med 358:985-7. 2008
  9. ncbi Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy
    William H Maisel
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Am J Ther 12:183-5. 2005
    ....
  10. ncbi Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease
    Gustavo Lopera
    Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Cardiovasc Electrophysiol 15:52-8. 2004
    ..Ablation often is not sufficient as the sole therapy due to other induced VT's and conduction abnormalities, requiring pacemaker and/or defibrillator implantation...
  11. ncbi Assessment of radiofrequency ablation effect from unipolar pacing threshold
    Etienne Delacretaz
    Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Pacing Clin Electrophysiol 26:1993-6. 2003
    ..The greater increase in pacing threshold after irrigated tip ablation compared to conventional ablation suggests that the magnitude of change reflects lesion size...
  12. ncbi Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007
    Daniel B Kramer
    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am J Ther 17:2-7. 2010
    ..Manufacturers, regulators, and the clinical community should collaborate to address these study shortcomings to ensure that patients are treated with reliable, safe, and clinically useful medical devices...
  13. ncbi Unanswered questions--drug-eluting stents and the risk of late thrombosis
    William H Maisel
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
    N Engl J Med 356:981-4. 2007
  14. ncbi Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy
    Daniel B Kramer
    Cardiovascular Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 107:1071-1075.e5. 2011
    ..In conclusion, patients who have, or are eligible to receive, CIEDs might require improved advance care planning and education regarding the ethical and legal options for managing CIEDs at the end of life...
  15. ncbi Impact of expanding indications on the safety of pacemakers and defibrillators
    William H Maisel
    Cardiac Arrhythmia Service, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Card Electrophysiol Rev 7:30-2. 2003
    ....
  16. ncbi Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories
    William H Maisel
    Cardiac Arrhythmia Service, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Pacing Clin Electrophysiol 25:1670-8. 2002
    ..Accurate, timely physician and patient notification systems, and routine pacemaker and ICD patient follow-up continue to be of paramount importance...
  17. ncbi Managing financial and nonfinancial conflicts of interest in healthcare delivery
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Ther 17:440-3. 2010
    ..The case history, device, physician, and patient described below do not represent actual people or events, but are intended to be emblematic of the challenges faced in the current medical marketplace...
  18. ncbi Malfunctions and adverse events associated with off-label use of biliary stents in the peripheral vasculature
    Jonathan Bridges
    Medical Device Safety Institute and Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    Am J Ther 15:12-8. 2008
    ..Efforts should be directed at improving the evaluation of peripheral vascular device performance to better identify the patient subsets that will most benefit from this promising therapy...
  19. ncbi The role of cardiac pacing: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery
    William H Maisel
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Chest 128:36S-38S. 2005
    ..We recommend that BAP be considered, particularly in patients who are at high risk for the development of postoperative AF...
  20. ncbi Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery
    Bruce A Koplan
    Cardiac Arrhythmia Service Division of Cardiology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 41:795-801. 2003
    ..The study objective was to develop and validate a simple risk score to predict postoperative permanent pacing (PPM) after valve surgery...
  21. ncbi Medical device regulation: an introduction for the practicing physician
    William H Maisel
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Ann Intern Med 140:296-302. 2004
    ..Physicians should understand the rules that govern the approved and unapproved use of medical devices as well as device premarket evaluation and approval processes and device postmarket surveillance...
  22. ncbi Management of arrhythmias in heart failure
    Kristin E Ellison
    Cardiovascular Division, Brigham and Womens Hospital, Boston, MA 02115, USA
    Congest Heart Fail 9:91-9. 2003
    ..The complexity of coexistent heart failure and arrhythmia management warrants close collaboration between heart failure and arrhythmia specialists...
  23. ncbi Physician management of pacemaker and implantable cardioverter defibrillator advisories
    William H Maisel
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Pacing Clin Electrophysiol 27:437-42. 2004
    ..Evidence based guidelines incorporating the indication for device implantation and the likelihood of device malfunction would greatly facilitate clinical management of PM and ICD advisory devices...
  24. ncbi Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials
    Akshay S Desai
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    JAMA 292:2874-9. 2004
    ..However, conclusive evidence of survival benefit in patients with nonischemic cardiomyopathy (NICM) is still lacking...
  25. ncbi Clinically significant magnetic interference of implanted cardiac devices by portable headphones
    Sinjin Lee
    Cardiovascular Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Heart Rhythm 6:1432-6. 2009
    ..Little is known about the magnetic field strength of portable headphones and their potential to cause magnetic interference with implanted pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs)...
  26. ncbi Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment
    Daniel B Kramer
    Cardiovascular Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02446, USA
    Heart Rhythm 7:1537-42. 2010
    ..Despite the high prevalence of pacemakers and implantable cardioverter-defibrillators, little is known about physicians' views surrounding the ethical and legal aspects of managing these devices at the end of life...
  27. ncbi Recalls and safety alerts affecting automated external defibrillators
    Jignesh S Shah
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass 02215, USA
    JAMA 296:655-60. 2006
    ..Efforts should be directed at developing a reliable system to locate and repair potentially defective devices in a timely fashion...
  28. ncbi Transvenous implantable cardioverter-defibrillator leads: the weakest link
    William H Maisel
    Circulation 115:2461-3. 2007
  29. ncbi Implantable cardioverter-defibrillator lead performance
    William H Maisel
    Circulation 117:2721-3. 2008
  30. ncbi Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006
    Warren K Laskey
    University of New Mexico Medical School, Albuquerque, USA
    Circulation 115:2352-7. 2007
  31. ncbi An unusual cause of abnormal intrathoracic impedance in a patient with arrhythmogenic right ventricular cardiomyopathy
    Daniel B Kramer
    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, Massachusetts 02215, USA
    Pacing Clin Electrophysiol 34:e60-3. 2011
    ..The strengths and limitations of intrathoracic impedance are described in the context of the physiology of pregnancy...
  32. ncbi Mortality following defibrillator implantation in patients with renal insufficiency
    Robert E Eckart
    Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    J Cardiovasc Electrophysiol 17:940-3. 2006
    ..Due to under-representation of patients with renal disease in large clinical trials, outcomes of implantable cardioverter defibrillator (ICD) implantation in this group remain unclear...
  33. ncbi Recognition of far-field electrograms during entrainment mapping of ventricular tachycardia
    Stanley Tung
    Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    J Am Coll Cardiol 42:110-5. 2003
    ..CONCLUSIONS: Far-field potentials are common during mapping in infarcts. Many can be distinguished from local potentials by entrainment, improving the accuracy of mapping...
  34. ncbi Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy
    William H Maisel
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Cardiol 91:2D-8D. 2003
    ..It will be critical to define and plan therapies specifically for those patients with AF, HF, and preserved ejection fraction in addition to the population with low ejection fraction that has dominated previous investigations...
  35. ncbi Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and
    Mark D Carlson
    University Hospitals of Cleveland and Case Western Reserve University, OH, USA
    Heart Rhythm 3:1250-73. 2006
  36. ncbi Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health: September 21, 2004
    William H Maisel
    US Food and Drug Administration, Circulatory System Devices Panel, Washington, DC, USA
    Circulation 111:2143-5. 2005
  37. ncbi Increased failure rate of a polyurethane implantable cardioverter defibrillator lead
    William H Maisel
    Pacing Clin Electrophysiol 25:877-8. 2002
  38. ncbi Management of arrhythmias in heart failure
    William G Stevenson
    Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA
    Cardiol Rev 10:8-14. 2002
    ..Ongoing trials will provide further guidance for arrhythmia management...
  39. ncbi Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation
    Kyoko Soejima
    Cardiovascular Division, Department of Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
    Circulation 106:1678-83. 2002
    ..The pacing threshold and electrogram amplitude that best determines EUS is unknown...
  40. ncbi Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection
    Ratika Parkash
    Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Am Heart J 151:397-403. 2006
    ..The objective of this study was to develop a model to predict mortality within the first year after ICD implantation...
  41. ncbi Cardiac resynchronization therapy: a regulatory perspective
    Warren K Laskey
    Am Heart J 151:757-61. 2006
  42. ncbi Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure
    Saman Nazarian
    Division of Cardiology, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am Heart J 150:955-60. 2005
    ..The aim of this study was to assess the impact of QRS duration and disease etiology on survival and rehospitalization in advanced heart failure patients with ICDs...